Given that USP52 is also a member of the USP family, we hypothesize that USP52 inhibition in combination with the ferroptosis inducer, erastin, can similarly promote CD8+ T-cell infiltration in the TME, thereby increasing the sensitivity of CRC to anti-PD-L1 treatment. This evidence concerns the gene CD274 and colorectal carcinoma.